Ann: Quarterly Update and Appendix 4C, page-34

Yes 3,500,000 assessments. Imagine what the data of those assessments and the outcomes would be worth to others? The medicine use or not use, the IP they have for Painchek, Painfaces, Trials done in hospitals and homecare data would be enormous. That's just the goodwill of the company, then the growth from last year to this year when you compare each quarter. its also huge. LOL $64 Mill MC on a company growing like crazy, compared to the RAP voice cough app that Pharma bought for what $180 Mill? And they had no real growth, About $7,000 was the best they did without advance payments from Jassen or Pizer! The management there was OMFG and we have a team of absolute legends.

So yes there was a pullback the last 24 hours, of course. Nothing goes up in a straight line, I was thinking we could get to 5.5c and we blasted to 7c. There is a share cafe webinar this Friday for PCK should be a good update/listen. We have the 4c in a few weeks that should show growth. I'm going with $756k for the Qtr, and if you compare that YoY then you can see where this company is headed, That is only aged care Painchek. Baby App, home care, hospitals are still well and truely possible. Some even before the end of the year! (We're in OCT). So I'm still bullish on PD and the team. I think even at the 7c we were way undervalued. If RAP was worth $180 Mill then PCK should be well over that estimate. That is a 3 bagger from here, and that is why we should cuurently be sitting anywhere between 11-14c. But unfortunately the market is currently not forward thinking, so we may need to see the 4c and another good Ann re- home care, Scotland, Wales, Baby App, Hospital trial or disability to name a few (). I am certainly in this for the long road, lets hope we don't get shafted like some of the poor RAP holders did. I know a few that avg over the end sale price and had been holding for 6 years, well done to management there.

Any other guesses on the 4c and is my estimate going to be good enough for the market to take note?